You are here: Industry Insights > Bharat Biotech

News List

DCGI expert committee allows clinical trials for third dose of Bharat Biotech’s Covaxin expresspharma
April 06, 2021
The expert panel of DCGI has permitted Bharat Biotech to give a third dose of Covaxin to a few volunteers in its clinical trials of the COVID-19 vaccine, sources said.
Anvisa says Covaxin producing facility does not meet CGMP standards expresspharma
April 01, 2021
The Brazilian health regulator Anvisa has denied permission to import Bharat Biotech’s COVID-19 vaccine Covaxin into the country after its authorities found that the plant in which the vaccine is being made did not meet the Current Good Manufacturing ...
Bharat Biotech, Biovet, Sapigen Biologix enter into research pact with CSIR-IICT expresspharma
March 30, 2021
To collaborate on the development of novel platform technologies for biotherapeutics and vaccines to support indigenous, affordable health care solutions for humans and animals.
Bharat Biotech announces Phase 3 results of COVAXIN®: India's first COVID-19 vaccine demonstrates interim clinical efficacy of 81% worldpharmanews
March 22, 2021
Bharat Biotech, a global leader in vaccine innovation, developing vaccines for infectious diseases, announced the first interim analysis of its BBV152 (COVAXIN®).
Covaxin granted restricted EUA expresspharma
March 12, 2021
Bharat Biotech’s indigenously developed Covaxin is out of the “clinical trial mode” and it has now been granted the restricted emergency use authorisation.
India’s Covaxin® 81 percent effective against COVID-19 europeanpharmaceuticalreview
March 09, 2021
An interim analysis reveals the Covaxin® (BBV152) vaccine was relatively safe and 81 percent effective in preventing symptomatic COVID-19.
Bharat Biotech’s Covid-19 vaccine shows interim efficacy of 81% pharmaceutical-technology
March 05, 2021
Indian firm Bharat Biotech has reported that the first interim analysis of Phase III study of its whole virion inactivated Covid-19 vaccine candidate, COVAXIN (BBV152), demonstrated clinical efficacy of 81%.
Bharat Biotech announces Phase III results of COVAXIN expresspharma
March 04, 2021
The trials involved 25,800 subjects, in partnership with the Indian Council of Medical Research.
Chinese hackers target Indian vaccine makers SII, Bharat Biotech, says security firm expresspharma
March 03, 2021
North Korean hackers also tried to break into the systems of British drugmaker AstraZeneca.
Liability for COVID vaccines in India: Where does the buck stop? expresspharma
March 02, 2021
A month into Indias country-wide vaccination drive that began in January 2021, and we have reportedly seen the death of 27 people already, including that of a 24-year-old medical intern, a mere 11 days after her vaccination.

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page